nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—AR—Ergocalciferol—osteoporosis	0.175	0.253	CbGbCtD
Mifepristone—ABCC1—Zoledronate—osteoporosis	0.114	0.165	CbGbCtD
Mifepristone—AR—Estradiol—osteoporosis	0.091	0.131	CbGbCtD
Mifepristone—ABCC1—Conjugated Estrogens—osteoporosis	0.0637	0.0919	CbGbCtD
Mifepristone—CYP3A7—Estradiol—osteoporosis	0.0276	0.0399	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0276	0.0399	CbGbCtD
Mifepristone—ABCB1—Ethinyl Estradiol—osteoporosis	0.0209	0.0302	CbGbCtD
Mifepristone—CYP3A5—Estradiol—osteoporosis	0.0207	0.0299	CbGbCtD
Mifepristone—CYP3A4—Calcitriol—osteoporosis	0.0195	0.0281	CbGbCtD
Mifepristone—CYP3A4—Estropipate—osteoporosis	0.0195	0.0281	CbGbCtD
Mifepristone—CYP2D6—Cholecalciferol—osteoporosis	0.0158	0.0227	CbGbCtD
Mifepristone—CYP3A4—Ergocalciferol—osteoporosis	0.0156	0.0224	CbGbCtD
Mifepristone—ABCB1—Conjugated Estrogens—osteoporosis	0.0154	0.0222	CbGbCtD
Mifepristone—ABCB1—Estradiol—osteoporosis	0.0135	0.0195	CbGbCtD
Mifepristone—CYP3A4—Raloxifene—osteoporosis	0.013	0.0187	CbGbCtD
Mifepristone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0125	0.0181	CbGbCtD
Mifepristone—CYP3A4—Cholecalciferol—osteoporosis	0.01	0.0145	CbGbCtD
Mifepristone—CYP3A4—Conjugated Estrogens—osteoporosis	0.0092	0.0133	CbGbCtD
Mifepristone—CYP3A4—Estradiol—osteoporosis	0.00808	0.0117	CbGbCtD
Mifepristone—Angioedema—Zoledronate—osteoporosis	0.000258	0.00102	CcSEcCtD
Mifepristone—Skin disorder—Risedronate—osteoporosis	0.000258	0.00102	CcSEcCtD
Mifepristone—Gastrointestinal pain—Calcitriol—osteoporosis	0.000258	0.00102	CcSEcCtD
Mifepristone—Body temperature increased—Raloxifene—osteoporosis	0.000257	0.00101	CcSEcCtD
Mifepristone—Abdominal pain—Raloxifene—osteoporosis	0.000257	0.00101	CcSEcCtD
Mifepristone—Urticaria—Ibandronate—osteoporosis	0.000256	0.00101	CcSEcCtD
Mifepristone—Malaise—Zoledronate—osteoporosis	0.000255	0.001	CcSEcCtD
Mifepristone—Abdominal pain—Ibandronate—osteoporosis	0.000255	0.001	CcSEcCtD
Mifepristone—Body temperature increased—Ibandronate—osteoporosis	0.000255	0.001	CcSEcCtD
Mifepristone—Oedema—Pamidronate—osteoporosis	0.000252	0.000996	CcSEcCtD
Mifepristone—Haemoglobin—Estradiol—osteoporosis	0.000251	0.000991	CcSEcCtD
Mifepristone—Infection—Pamidronate—osteoporosis	0.000251	0.000989	CcSEcCtD
Mifepristone—Urticaria—Calcitriol—osteoporosis	0.00025	0.000988	CcSEcCtD
Mifepristone—Haemorrhage—Estradiol—osteoporosis	0.00025	0.000986	CcSEcCtD
Mifepristone—Abdominal pain—Calcitriol—osteoporosis	0.000249	0.000983	CcSEcCtD
Mifepristone—Body temperature increased—Calcitriol—osteoporosis	0.000249	0.000983	CcSEcCtD
Mifepristone—Angioedema—Conjugated Estrogens—osteoporosis	0.000248	0.00098	CcSEcCtD
Mifepristone—Hypersensitivity—Estropipate—osteoporosis	0.000247	0.000976	CcSEcCtD
Mifepristone—Nervous system disorder—Pamidronate—osteoporosis	0.000247	0.000976	CcSEcCtD
Mifepristone—Vomiting—Etidronic acid—osteoporosis	0.000247	0.000974	CcSEcCtD
Mifepristone—Oedema peripheral—Estradiol—osteoporosis	0.000246	0.000972	CcSEcCtD
Mifepristone—Connective tissue disorder—Estradiol—osteoporosis	0.000246	0.000969	CcSEcCtD
Mifepristone—Rash—Etidronic acid—osteoporosis	0.000245	0.000966	CcSEcCtD
Mifepristone—Dermatitis—Etidronic acid—osteoporosis	0.000244	0.000965	CcSEcCtD
Mifepristone—Hypertension—Zoledronate—osteoporosis	0.000244	0.000962	CcSEcCtD
Mifepristone—Hypersensitivity—Alendronate—osteoporosis	0.000244	0.000962	CcSEcCtD
Mifepristone—Headache—Etidronic acid—osteoporosis	0.000243	0.00096	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000242	0.000954	CcSEcCtD
Mifepristone—Asthenia—Estropipate—osteoporosis	0.000241	0.000951	CcSEcCtD
Mifepristone—Anorexia—Pamidronate—osteoporosis	0.00024	0.000949	CcSEcCtD
Mifepristone—Myalgia—Zoledronate—osteoporosis	0.00024	0.000949	CcSEcCtD
Mifepristone—Arthralgia—Zoledronate—osteoporosis	0.00024	0.000949	CcSEcCtD
Mifepristone—Insomnia—Risedronate—osteoporosis	0.00024	0.000947	CcSEcCtD
Mifepristone—Anxiety—Zoledronate—osteoporosis	0.00024	0.000945	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000239	0.000942	CcSEcCtD
Mifepristone—Pruritus—Estropipate—osteoporosis	0.000238	0.000938	CcSEcCtD
Mifepristone—Discomfort—Zoledronate—osteoporosis	0.000237	0.000937	CcSEcCtD
Mifepristone—Asthenia—Alendronate—osteoporosis	0.000237	0.000937	CcSEcCtD
Mifepristone—Hypersensitivity—Ibandronate—osteoporosis	0.000237	0.000936	CcSEcCtD
Mifepristone—Dyspnoea—Risedronate—osteoporosis	0.000237	0.000934	CcSEcCtD
Mifepristone—Hypotension—Pamidronate—osteoporosis	0.000236	0.00093	CcSEcCtD
Mifepristone—Dry mouth—Zoledronate—osteoporosis	0.000235	0.000928	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000235	0.000927	CcSEcCtD
Mifepristone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000235	0.000926	CcSEcCtD
Mifepristone—Pruritus—Alendronate—osteoporosis	0.000234	0.000923	CcSEcCtD
Mifepristone—Constipation—Ethinyl Estradiol—osteoporosis	0.000233	0.000919	CcSEcCtD
Mifepristone—Hypersensitivity—Calcitriol—osteoporosis	0.000232	0.000917	CcSEcCtD
Mifepristone—Arthralgia—Conjugated Estrogens—osteoporosis	0.000231	0.000913	CcSEcCtD
Mifepristone—Myalgia—Conjugated Estrogens—osteoporosis	0.000231	0.000913	CcSEcCtD
Mifepristone—Asthenia—Ibandronate—osteoporosis	0.000231	0.000912	CcSEcCtD
Mifepristone—Anxiety—Conjugated Estrogens—osteoporosis	0.000231	0.00091	CcSEcCtD
Mifepristone—Nausea—Etidronic acid—osteoporosis	0.000231	0.00091	CcSEcCtD
Mifepristone—Oedema—Zoledronate—osteoporosis	0.00023	0.000909	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00023	0.000907	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00023	0.000907	CcSEcCtD
Mifepristone—Diarrhoea—Estropipate—osteoporosis	0.00023	0.000907	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Risedronate—osteoporosis	0.000229	0.000904	CcSEcCtD
Mifepristone—Infection—Zoledronate—osteoporosis	0.000229	0.000903	CcSEcCtD
Mifepristone—Fatigue—Risedronate—osteoporosis	0.000229	0.000903	CcSEcCtD
Mifepristone—Insomnia—Pamidronate—osteoporosis	0.000228	0.0009	CcSEcCtD
Mifepristone—Pruritus—Ibandronate—osteoporosis	0.000228	0.000899	CcSEcCtD
Mifepristone—Pain—Risedronate—osteoporosis	0.000227	0.000896	CcSEcCtD
Mifepristone—Constipation—Risedronate—osteoporosis	0.000227	0.000896	CcSEcCtD
Mifepristone—Angiopathy—Estradiol—osteoporosis	0.000227	0.000895	CcSEcCtD
Mifepristone—Diarrhoea—Alendronate—osteoporosis	0.000226	0.000893	CcSEcCtD
Mifepristone—Asthenia—Calcitriol—osteoporosis	0.000226	0.000893	CcSEcCtD
Mifepristone—Nervous system disorder—Zoledronate—osteoporosis	0.000226	0.000892	CcSEcCtD
Mifepristone—Mediastinal disorder—Estradiol—osteoporosis	0.000225	0.000889	CcSEcCtD
Mifepristone—Dyspnoea—Pamidronate—osteoporosis	0.000225	0.000888	CcSEcCtD
Mifepristone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000224	0.000885	CcSEcCtD
Mifepristone—Chills—Estradiol—osteoporosis	0.000224	0.000885	CcSEcCtD
Mifepristone—Somnolence—Pamidronate—osteoporosis	0.000224	0.000885	CcSEcCtD
Mifepristone—Skin disorder—Zoledronate—osteoporosis	0.000224	0.000883	CcSEcCtD
Mifepristone—Pruritus—Calcitriol—osteoporosis	0.000223	0.00088	CcSEcCtD
Mifepristone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000223	0.000878	CcSEcCtD
Mifepristone—Diarrhoea—Raloxifene—osteoporosis	0.000223	0.000878	CcSEcCtD
Mifepristone—Dizziness—Estropipate—osteoporosis	0.000222	0.000876	CcSEcCtD
Mifepristone—Oedema—Conjugated Estrogens—osteoporosis	0.000222	0.000876	CcSEcCtD
Mifepristone—Infection—Conjugated Estrogens—osteoporosis	0.00022	0.00087	CcSEcCtD
Mifepristone—Diarrhoea—Ibandronate—osteoporosis	0.00022	0.00087	CcSEcCtD
Mifepristone—Anorexia—Zoledronate—osteoporosis	0.00022	0.000867	CcSEcCtD
Mifepristone—Decreased appetite—Pamidronate—osteoporosis	0.000219	0.000865	CcSEcCtD
Mifepristone—Mental disorder—Estradiol—osteoporosis	0.000219	0.000864	CcSEcCtD
Mifepristone—Dizziness—Alendronate—osteoporosis	0.000219	0.000863	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000218	0.00086	CcSEcCtD
Mifepristone—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000218	0.000859	CcSEcCtD
Mifepristone—Malnutrition—Estradiol—osteoporosis	0.000218	0.000859	CcSEcCtD
Mifepristone—Fatigue—Pamidronate—osteoporosis	0.000217	0.000858	CcSEcCtD
Mifepristone—Gastrointestinal pain—Risedronate—osteoporosis	0.000217	0.000856	CcSEcCtD
Mifepristone—Urticaria—Ethinyl Estradiol—osteoporosis	0.000216	0.000853	CcSEcCtD
Mifepristone—Constipation—Pamidronate—osteoporosis	0.000216	0.000851	CcSEcCtD
Mifepristone—Pain—Pamidronate—osteoporosis	0.000216	0.000851	CcSEcCtD
Mifepristone—Diarrhoea—Calcitriol—osteoporosis	0.000216	0.000851	CcSEcCtD
Mifepristone—Skin disorder—Conjugated Estrogens—osteoporosis	0.000215	0.000851	CcSEcCtD
Mifepristone—Hypotension—Zoledronate—osteoporosis	0.000215	0.00085	CcSEcCtD
Mifepristone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000215	0.000849	CcSEcCtD
Mifepristone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000215	0.000849	CcSEcCtD
Mifepristone—Dizziness—Raloxifene—osteoporosis	0.000215	0.000849	CcSEcCtD
Mifepristone—Vomiting—Estropipate—osteoporosis	0.000213	0.000843	CcSEcCtD
Mifepristone—Dizziness—Ibandronate—osteoporosis	0.000213	0.00084	CcSEcCtD
Mifepristone—Rash—Estropipate—osteoporosis	0.000212	0.000836	CcSEcCtD
Mifepristone—Dermatitis—Estropipate—osteoporosis	0.000211	0.000835	CcSEcCtD
Mifepristone—Anorexia—Conjugated Estrogens—osteoporosis	0.000211	0.000835	CcSEcCtD
Mifepristone—Urticaria—Risedronate—osteoporosis	0.000211	0.000832	CcSEcCtD
Mifepristone—Back pain—Estradiol—osteoporosis	0.00021	0.000831	CcSEcCtD
Mifepristone—Headache—Estropipate—osteoporosis	0.00021	0.00083	CcSEcCtD
Mifepristone—Vomiting—Alendronate—osteoporosis	0.00021	0.00083	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00021	0.000829	CcSEcCtD
Mifepristone—Body temperature increased—Risedronate—osteoporosis	0.00021	0.000828	CcSEcCtD
Mifepristone—Abdominal pain—Risedronate—osteoporosis	0.00021	0.000828	CcSEcCtD
Mifepristone—Muscle spasms—Estradiol—osteoporosis	0.000209	0.000826	CcSEcCtD
Mifepristone—Rash—Alendronate—osteoporosis	0.000209	0.000823	CcSEcCtD
Mifepristone—Insomnia—Zoledronate—osteoporosis	0.000208	0.000823	CcSEcCtD
Mifepristone—Dermatitis—Alendronate—osteoporosis	0.000208	0.000822	CcSEcCtD
Mifepristone—Feeling abnormal—Pamidronate—osteoporosis	0.000208	0.00082	CcSEcCtD
Mifepristone—Hypotension—Conjugated Estrogens—osteoporosis	0.000207	0.000818	CcSEcCtD
Mifepristone—Headache—Alendronate—osteoporosis	0.000207	0.000818	CcSEcCtD
Mifepristone—Vomiting—Raloxifene—osteoporosis	0.000207	0.000816	CcSEcCtD
Mifepristone—Gastrointestinal pain—Pamidronate—osteoporosis	0.000206	0.000814	CcSEcCtD
Mifepristone—Dyspnoea—Zoledronate—osteoporosis	0.000205	0.000811	CcSEcCtD
Mifepristone—Rash—Raloxifene—osteoporosis	0.000205	0.000809	CcSEcCtD
Mifepristone—Dermatitis—Raloxifene—osteoporosis	0.000205	0.000809	CcSEcCtD
Mifepristone—Somnolence—Zoledronate—osteoporosis	0.000205	0.000808	CcSEcCtD
Mifepristone—Vomiting—Ibandronate—osteoporosis	0.000205	0.000808	CcSEcCtD
Mifepristone—Headache—Raloxifene—osteoporosis	0.000204	0.000804	CcSEcCtD
Mifepristone—Rash—Ibandronate—osteoporosis	0.000203	0.000801	CcSEcCtD
Mifepristone—Dermatitis—Ibandronate—osteoporosis	0.000203	0.000801	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000202	0.000798	CcSEcCtD
Mifepristone—Ill-defined disorder—Estradiol—osteoporosis	0.000202	0.000797	CcSEcCtD
Mifepristone—Headache—Ibandronate—osteoporosis	0.000202	0.000796	CcSEcCtD
Mifepristone—Insomnia—Conjugated Estrogens—osteoporosis	0.000201	0.000792	CcSEcCtD
Mifepristone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000201	0.000791	CcSEcCtD
Mifepristone—Vomiting—Calcitriol—osteoporosis	0.0002	0.000791	CcSEcCtD
Mifepristone—Decreased appetite—Zoledronate—osteoporosis	0.0002	0.000791	CcSEcCtD
Mifepristone—Nausea—Estropipate—osteoporosis	0.000199	0.000787	CcSEcCtD
Mifepristone—Abdominal pain—Pamidronate—osteoporosis	0.000199	0.000787	CcSEcCtD
Mifepristone—Body temperature increased—Pamidronate—osteoporosis	0.000199	0.000787	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000199	0.000785	CcSEcCtD
Mifepristone—Angioedema—Estradiol—osteoporosis	0.000199	0.000785	CcSEcCtD
Mifepristone—Rash—Calcitriol—osteoporosis	0.000199	0.000784	CcSEcCtD
Mifepristone—Fatigue—Zoledronate—osteoporosis	0.000199	0.000784	CcSEcCtD
Mifepristone—Dermatitis—Calcitriol—osteoporosis	0.000199	0.000784	CcSEcCtD
Mifepristone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000198	0.000781	CcSEcCtD
Mifepristone—Headache—Calcitriol—osteoporosis	0.000197	0.000779	CcSEcCtD
Mifepristone—Somnolence—Conjugated Estrogens—osteoporosis	0.000197	0.000778	CcSEcCtD
Mifepristone—Pain—Zoledronate—osteoporosis	0.000197	0.000778	CcSEcCtD
Mifepristone—Constipation—Zoledronate—osteoporosis	0.000197	0.000778	CcSEcCtD
Mifepristone—Nausea—Alendronate—osteoporosis	0.000196	0.000775	CcSEcCtD
Mifepristone—Malaise—Estradiol—osteoporosis	0.000196	0.000774	CcSEcCtD
Mifepristone—Hypersensitivity—Risedronate—osteoporosis	0.000195	0.000772	CcSEcCtD
Mifepristone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000195	0.000771	CcSEcCtD
Mifepristone—Nausea—Raloxifene—osteoporosis	0.000193	0.000762	CcSEcCtD
Mifepristone—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000193	0.000761	CcSEcCtD
Mifepristone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000193	0.00076	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000192	0.000756	CcSEcCtD
Mifepristone—Fatigue—Conjugated Estrogens—osteoporosis	0.000191	0.000755	CcSEcCtD
Mifepristone—Nausea—Ibandronate—osteoporosis	0.000191	0.000755	CcSEcCtD
Mifepristone—Asthenia—Risedronate—osteoporosis	0.00019	0.000751	CcSEcCtD
Mifepristone—Feeling abnormal—Zoledronate—osteoporosis	0.00019	0.000749	CcSEcCtD
Mifepristone—Pain—Conjugated Estrogens—osteoporosis	0.00019	0.000749	CcSEcCtD
Mifepristone—Constipation—Conjugated Estrogens—osteoporosis	0.00019	0.000749	CcSEcCtD
Mifepristone—Gastrointestinal pain—Zoledronate—osteoporosis	0.000188	0.000744	CcSEcCtD
Mifepristone—Hypertension—Estradiol—osteoporosis	0.000188	0.000741	CcSEcCtD
Mifepristone—Pruritus—Risedronate—osteoporosis	0.000188	0.000741	CcSEcCtD
Mifepristone—Nausea—Calcitriol—osteoporosis	0.000187	0.000739	CcSEcCtD
Mifepristone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000186	0.000735	CcSEcCtD
Mifepristone—Hypersensitivity—Pamidronate—osteoporosis	0.000186	0.000734	CcSEcCtD
Mifepristone—Myalgia—Estradiol—osteoporosis	0.000185	0.000731	CcSEcCtD
Mifepristone—Arthralgia—Estradiol—osteoporosis	0.000185	0.000731	CcSEcCtD
Mifepristone—Anxiety—Estradiol—osteoporosis	0.000185	0.000729	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000184	0.000726	CcSEcCtD
Mifepristone—Urticaria—Zoledronate—osteoporosis	0.000183	0.000722	CcSEcCtD
Mifepristone—Discomfort—Estradiol—osteoporosis	0.000183	0.000722	CcSEcCtD
Mifepristone—Body temperature increased—Zoledronate—osteoporosis	0.000182	0.000719	CcSEcCtD
Mifepristone—Abdominal pain—Zoledronate—osteoporosis	0.000182	0.000719	CcSEcCtD
Mifepristone—Diarrhoea—Risedronate—osteoporosis	0.000182	0.000717	CcSEcCtD
Mifepristone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000181	0.000716	CcSEcCtD
Mifepristone—Dry mouth—Estradiol—osteoporosis	0.000181	0.000715	CcSEcCtD
Mifepristone—Asthenia—Pamidronate—osteoporosis	0.000181	0.000714	CcSEcCtD
Mifepristone—Dizziness—Ethinyl Estradiol—osteoporosis	0.00018	0.00071	CcSEcCtD
Mifepristone—Pruritus—Pamidronate—osteoporosis	0.000178	0.000704	CcSEcCtD
Mifepristone—Oedema—Estradiol—osteoporosis	0.000178	0.000701	CcSEcCtD
Mifepristone—Infection—Estradiol—osteoporosis	0.000176	0.000696	CcSEcCtD
Mifepristone—Urticaria—Conjugated Estrogens—osteoporosis	0.000176	0.000696	CcSEcCtD
Mifepristone—Dizziness—Risedronate—osteoporosis	0.000175	0.000693	CcSEcCtD
Mifepristone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000175	0.000692	CcSEcCtD
Mifepristone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000175	0.000692	CcSEcCtD
Mifepristone—Nervous system disorder—Estradiol—osteoporosis	0.000174	0.000687	CcSEcCtD
Mifepristone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000173	0.000683	CcSEcCtD
Mifepristone—Diarrhoea—Pamidronate—osteoporosis	0.000173	0.000681	CcSEcCtD
Mifepristone—Skin disorder—Estradiol—osteoporosis	0.000172	0.000681	CcSEcCtD
Mifepristone—Rash—Ethinyl Estradiol—osteoporosis	0.000172	0.000677	CcSEcCtD
Mifepristone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000171	0.000677	CcSEcCtD
Mifepristone—Headache—Ethinyl Estradiol—osteoporosis	0.00017	0.000673	CcSEcCtD
Mifepristone—Hypersensitivity—Zoledronate—osteoporosis	0.00017	0.00067	CcSEcCtD
Mifepristone—Vomiting—Risedronate—osteoporosis	0.000169	0.000666	CcSEcCtD
Mifepristone—Rash—Risedronate—osteoporosis	0.000167	0.00066	CcSEcCtD
Mifepristone—Dermatitis—Risedronate—osteoporosis	0.000167	0.00066	CcSEcCtD
Mifepristone—Dizziness—Pamidronate—osteoporosis	0.000167	0.000658	CcSEcCtD
Mifepristone—Headache—Risedronate—osteoporosis	0.000166	0.000656	CcSEcCtD
Mifepristone—Asthenia—Zoledronate—osteoporosis	0.000165	0.000652	CcSEcCtD
Mifepristone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000163	0.000645	CcSEcCtD
Mifepristone—Pruritus—Zoledronate—osteoporosis	0.000163	0.000643	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000162	0.000639	CcSEcCtD
Mifepristone—Nausea—Ethinyl Estradiol—osteoporosis	0.000162	0.000638	CcSEcCtD
Mifepristone—Insomnia—Estradiol—osteoporosis	0.000161	0.000634	CcSEcCtD
Mifepristone—Vomiting—Pamidronate—osteoporosis	0.00016	0.000633	CcSEcCtD
Mifepristone—Asthenia—Conjugated Estrogens—osteoporosis	0.000159	0.000628	CcSEcCtD
Mifepristone—Rash—Pamidronate—osteoporosis	0.000159	0.000628	CcSEcCtD
Mifepristone—Dermatitis—Pamidronate—osteoporosis	0.000159	0.000627	CcSEcCtD
Mifepristone—Dyspnoea—Estradiol—osteoporosis	0.000158	0.000625	CcSEcCtD
Mifepristone—Headache—Pamidronate—osteoporosis	0.000158	0.000624	CcSEcCtD
Mifepristone—Somnolence—Estradiol—osteoporosis	0.000158	0.000623	CcSEcCtD
Mifepristone—Diarrhoea—Zoledronate—osteoporosis	0.000158	0.000622	CcSEcCtD
Mifepristone—Nausea—Risedronate—osteoporosis	0.000158	0.000622	CcSEcCtD
Mifepristone—Pruritus—Conjugated Estrogens—osteoporosis	0.000157	0.00062	CcSEcCtD
Mifepristone—Decreased appetite—Estradiol—osteoporosis	0.000154	0.000609	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Estradiol—osteoporosis	0.000153	0.000605	CcSEcCtD
Mifepristone—Fatigue—Estradiol—osteoporosis	0.000153	0.000604	CcSEcCtD
Mifepristone—Dizziness—Zoledronate—osteoporosis	0.000152	0.000601	CcSEcCtD
Mifepristone—Constipation—Estradiol—osteoporosis	0.000152	0.000599	CcSEcCtD
Mifepristone—Pain—Estradiol—osteoporosis	0.000152	0.000599	CcSEcCtD
Mifepristone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000152	0.000599	CcSEcCtD
Mifepristone—Nausea—Pamidronate—osteoporosis	0.00015	0.000591	CcSEcCtD
Mifepristone—Dizziness—Conjugated Estrogens—osteoporosis	0.000147	0.000579	CcSEcCtD
Mifepristone—Vomiting—Zoledronate—osteoporosis	0.000146	0.000578	CcSEcCtD
Mifepristone—Feeling abnormal—Estradiol—osteoporosis	0.000146	0.000578	CcSEcCtD
Mifepristone—Rash—Zoledronate—osteoporosis	0.000145	0.000573	CcSEcCtD
Mifepristone—Gastrointestinal pain—Estradiol—osteoporosis	0.000145	0.000573	CcSEcCtD
Mifepristone—Dermatitis—Zoledronate—osteoporosis	0.000145	0.000573	CcSEcCtD
Mifepristone—Headache—Zoledronate—osteoporosis	0.000144	0.00057	CcSEcCtD
Mifepristone—Vomiting—Conjugated Estrogens—osteoporosis	0.000141	0.000557	CcSEcCtD
Mifepristone—Urticaria—Estradiol—osteoporosis	0.000141	0.000557	CcSEcCtD
Mifepristone—Abdominal pain—Estradiol—osteoporosis	0.00014	0.000554	CcSEcCtD
Mifepristone—Body temperature increased—Estradiol—osteoporosis	0.00014	0.000554	CcSEcCtD
Mifepristone—Rash—Conjugated Estrogens—osteoporosis	0.00014	0.000552	CcSEcCtD
Mifepristone—Dermatitis—Conjugated Estrogens—osteoporosis	0.00014	0.000552	CcSEcCtD
Mifepristone—Headache—Conjugated Estrogens—osteoporosis	0.000139	0.000549	CcSEcCtD
Mifepristone—Nausea—Zoledronate—osteoporosis	0.000137	0.00054	CcSEcCtD
Mifepristone—Nausea—Conjugated Estrogens—osteoporosis	0.000132	0.00052	CcSEcCtD
Mifepristone—Hypersensitivity—Estradiol—osteoporosis	0.000131	0.000516	CcSEcCtD
Mifepristone—Asthenia—Estradiol—osteoporosis	0.000127	0.000503	CcSEcCtD
Mifepristone—Pruritus—Estradiol—osteoporosis	0.000126	0.000496	CcSEcCtD
Mifepristone—Diarrhoea—Estradiol—osteoporosis	0.000121	0.00048	CcSEcCtD
Mifepristone—Dizziness—Estradiol—osteoporosis	0.000117	0.000463	CcSEcCtD
Mifepristone—Vomiting—Estradiol—osteoporosis	0.000113	0.000446	CcSEcCtD
Mifepristone—Rash—Estradiol—osteoporosis	0.000112	0.000442	CcSEcCtD
Mifepristone—Dermatitis—Estradiol—osteoporosis	0.000112	0.000441	CcSEcCtD
Mifepristone—Headache—Estradiol—osteoporosis	0.000111	0.000439	CcSEcCtD
Mifepristone—Nausea—Estradiol—osteoporosis	0.000105	0.000416	CcSEcCtD
Mifepristone—ABCC1—Disease—LRP6—osteoporosis	5.57e-05	0.00104	CbGpPWpGaD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	5.54e-05	0.00103	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—MYC—osteoporosis	5.53e-05	0.00103	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	5.51e-05	0.00103	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	5.47e-05	0.00102	CbGpPWpGaD
Mifepristone—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	5.43e-05	0.00101	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—IL6—osteoporosis	5.42e-05	0.00101	CbGpPWpGaD
Mifepristone—ABCC1—Disease—RPL24—osteoporosis	5.36e-05	0.001	CbGpPWpGaD
Mifepristone—ABCC1—Disease—LTF—osteoporosis	5.36e-05	0.001	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ATIC—osteoporosis	5.26e-05	0.000982	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PNP—osteoporosis	5.26e-05	0.000982	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	5.24e-05	0.000979	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	5.14e-05	0.000959	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—OXCT1—osteoporosis	5.13e-05	0.000958	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CA2—osteoporosis	5.13e-05	0.000958	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—RPL24—osteoporosis	5.11e-05	0.000953	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—PSMA2—osteoporosis	5.1e-05	0.000952	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—PSMA5—osteoporosis	5.1e-05	0.000952	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TLN1—osteoporosis	5.05e-05	0.000943	CbGpPWpGaD
Mifepristone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.02e-05	0.000938	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—TNF—osteoporosis	5.02e-05	0.000936	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—MGLL—osteoporosis	5e-05	0.000933	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL1B—osteoporosis	4.86e-05	0.000906	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.72e-05	0.00088	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—TGFB1—osteoporosis	4.71e-05	0.00088	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—POMC—osteoporosis	4.65e-05	0.000868	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.65e-05	0.000867	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ACP5—osteoporosis	4.64e-05	0.000867	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	4.58e-05	0.000855	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	4.57e-05	0.000853	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—ESR2—osteoporosis	4.56e-05	0.00085	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CA2—osteoporosis	4.48e-05	0.000835	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—OXCT1—osteoporosis	4.48e-05	0.000835	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—TNF—osteoporosis	4.4e-05	0.000822	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—FDPS—osteoporosis	4.39e-05	0.000819	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PKM—osteoporosis	4.39e-05	0.000819	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—ESR1—osteoporosis	4.37e-05	0.000816	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—MGLL—osteoporosis	4.36e-05	0.000814	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—P4HB—osteoporosis	4.35e-05	0.000813	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	4.34e-05	0.00081	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TPI1—osteoporosis	4.32e-05	0.000806	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	4.27e-05	0.000796	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—IDH2—osteoporosis	4.25e-05	0.000794	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTH—osteoporosis	4.24e-05	0.000791	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RAP1A—osteoporosis	4.16e-05	0.000777	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PGLS—osteoporosis	4.16e-05	0.000776	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GPD2—osteoporosis	4.16e-05	0.000776	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CNR2—osteoporosis	4.13e-05	0.00077	CbGpPWpGaD
Mifepristone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.07e-05	0.00076	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NFATC1—osteoporosis	4.06e-05	0.000758	CbGpPWpGaD
Mifepristone—ABCC1—Disease—P4HB—osteoporosis	4.06e-05	0.000758	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—IL6—osteoporosis	4.05e-05	0.000755	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—DKK1—osteoporosis	4.03e-05	0.000752	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP27A1—osteoporosis	4e-05	0.000746	CbGpPWpGaD
Mifepristone—ABCC1—Disease—GAPDH—osteoporosis	3.98e-05	0.000744	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ACP5—osteoporosis	3.89e-05	0.000726	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PSMA2—osteoporosis	3.89e-05	0.000725	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PSMA5—osteoporosis	3.89e-05	0.000725	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—WNT1—osteoporosis	3.88e-05	0.000724	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.84e-05	0.000717	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	3.81e-05	0.00071	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ATIC—osteoporosis	3.81e-05	0.00071	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PNP—osteoporosis	3.81e-05	0.00071	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NFATC1—osteoporosis	3.79e-05	0.000707	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FGA—osteoporosis	3.78e-05	0.000705	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TGFB1—osteoporosis	3.77e-05	0.000704	CbGpPWpGaD
Mifepristone—ABCC1—Disease—DKK1—osteoporosis	3.76e-05	0.000701	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—IDH2—osteoporosis	3.71e-05	0.000692	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.66e-05	0.000684	CbGpPWpGaD
Mifepristone—ABCC1—Disease—WNT1—osteoporosis	3.62e-05	0.000675	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—VDR—osteoporosis	3.62e-05	0.000675	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—TPI1—osteoporosis	3.62e-05	0.000675	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.6e-05	0.000672	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	3.59e-05	0.00067	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—IL6—osteoporosis	3.55e-05	0.000663	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.55e-05	0.000663	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TNF—osteoporosis	3.52e-05	0.000658	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGA—osteoporosis	3.52e-05	0.000657	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—BMP2—osteoporosis	3.51e-05	0.000655	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTHLH—osteoporosis	3.51e-05	0.000655	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP27A1—osteoporosis	3.49e-05	0.000651	CbGpPWpGaD
Mifepristone—AR—Gene Expression—ESR2—osteoporosis	3.47e-05	0.000648	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FGB—osteoporosis	3.44e-05	0.000641	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—P4HB—osteoporosis	3.4e-05	0.000634	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ACP5—osteoporosis	3.39e-05	0.000633	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GAPDH—osteoporosis	3.34e-05	0.000623	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	3.32e-05	0.000619	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PSMA2—osteoporosis	3.32e-05	0.000619	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PSMA5—osteoporosis	3.32e-05	0.000619	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PKM—osteoporosis	3.31e-05	0.000618	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—FDPS—osteoporosis	3.31e-05	0.000618	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—POMC—osteoporosis	3.31e-05	0.000617	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—RAP1A—osteoporosis	3.25e-05	0.000607	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CA2—osteoporosis	3.24e-05	0.000604	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—OXCT1—osteoporosis	3.24e-05	0.000604	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TPI1—osteoporosis	3.15e-05	0.000589	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MGLL—osteoporosis	3.15e-05	0.000588	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GPD2—osteoporosis	3.14e-05	0.000586	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PGLS—osteoporosis	3.14e-05	0.000586	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ENO1—osteoporosis	3.14e-05	0.000585	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PKM—osteoporosis	3.12e-05	0.000582	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—FDPS—osteoporosis	3.12e-05	0.000582	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.11e-05	0.00058	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PSMA5—osteoporosis	3.09e-05	0.000577	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PSMA2—osteoporosis	3.09e-05	0.000577	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CALCA—osteoporosis	3.09e-05	0.000577	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	3.07e-05	0.000573	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—MYC—osteoporosis	2.99e-05	0.000557	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—P4HB—osteoporosis	2.96e-05	0.000553	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PGLS—osteoporosis	2.96e-05	0.000552	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GPD2—osteoporosis	2.96e-05	0.000552	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PSMA5—osteoporosis	2.95e-05	0.00055	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PSMA2—osteoporosis	2.95e-05	0.00055	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GAPDH—osteoporosis	2.91e-05	0.000543	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CALCA—osteoporosis	2.88e-05	0.000538	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PNP—osteoporosis	2.87e-05	0.000536	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ATIC—osteoporosis	2.87e-05	0.000536	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—RAP1A—osteoporosis	2.83e-05	0.000529	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.83e-05	0.000529	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KL—osteoporosis	2.81e-05	0.000524	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—ESR1—osteoporosis	2.76e-05	0.000516	CbGpPWpGaD
Mifepristone—AR—Gene Expression—VDR—osteoporosis	2.76e-05	0.000514	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ATIC—osteoporosis	2.71e-05	0.000505	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PNP—osteoporosis	2.71e-05	0.000505	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—IDH2—osteoporosis	2.68e-05	0.0005	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ESR2—osteoporosis	2.63e-05	0.000492	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ENO1—osteoporosis	2.63e-05	0.00049	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KL—osteoporosis	2.62e-05	0.000488	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PSMA2—osteoporosis	2.59e-05	0.000483	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PSMA5—osteoporosis	2.59e-05	0.000483	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP27A1—osteoporosis	2.52e-05	0.00047	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ACP5—osteoporosis	2.45e-05	0.000458	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CA2—osteoporosis	2.44e-05	0.000456	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—OXCT1—osteoporosis	2.44e-05	0.000456	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MGLL—osteoporosis	2.38e-05	0.000444	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CA2—osteoporosis	2.3e-05	0.000429	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—OXCT1—osteoporosis	2.3e-05	0.000429	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ENO1—osteoporosis	2.29e-05	0.000428	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TPI1—osteoporosis	2.28e-05	0.000425	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—MYC—osteoporosis	2.27e-05	0.000425	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PSMA2—osteoporosis	2.26e-05	0.000421	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PSMA5—osteoporosis	2.26e-05	0.000421	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MGLL—osteoporosis	2.24e-05	0.000418	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ADCY5—osteoporosis	2.2e-05	0.00041	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—POMC—osteoporosis	2.16e-05	0.000404	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—P4HB—osteoporosis	2.14e-05	0.0004	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SPP1—osteoporosis	2.13e-05	0.000397	CbGpPWpGaD
Mifepristone—AR—Gene Expression—ESR1—osteoporosis	2.11e-05	0.000393	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GAPDH—osteoporosis	2.1e-05	0.000393	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP19A1—osteoporosis	2.1e-05	0.000392	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—VDR—osteoporosis	2.09e-05	0.00039	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ADCY5—osteoporosis	2.05e-05	0.000382	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—RAP1A—osteoporosis	2.05e-05	0.000382	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PKM—osteoporosis	2.04e-05	0.000381	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—FDPS—osteoporosis	2.04e-05	0.000381	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—IDH2—osteoporosis	2.02e-05	0.000378	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PGLS—osteoporosis	1.93e-05	0.000361	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GPD2—osteoporosis	1.93e-05	0.000361	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IRS2—osteoporosis	1.92e-05	0.000359	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—IDH2—osteoporosis	1.91e-05	0.000356	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP27A1—osteoporosis	1.9e-05	0.000355	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MTHFR—osteoporosis	1.88e-05	0.000352	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—LEP—osteoporosis	1.88e-05	0.000351	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.87e-05	0.000348	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.86e-05	0.000347	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ACP5—osteoporosis	1.85e-05	0.000345	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.83e-05	0.000342	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ESR1—osteoporosis	1.8e-05	0.000335	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IRS2—osteoporosis	1.79e-05	0.000335	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.79e-05	0.000334	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PNP—osteoporosis	1.77e-05	0.00033	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ATIC—osteoporosis	1.77e-05	0.00033	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ACP5—osteoporosis	1.74e-05	0.000325	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.74e-05	0.000325	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.74e-05	0.000324	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	1.73e-05	0.000322	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TPI1—osteoporosis	1.72e-05	0.000321	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ADCY5—osteoporosis	1.72e-05	0.00032	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GPX1—osteoporosis	1.71e-05	0.000319	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IRS1—osteoporosis	1.68e-05	0.000313	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ENO1—osteoporosis	1.66e-05	0.000309	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PSMA5—osteoporosis	1.63e-05	0.000305	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PSMA2—osteoporosis	1.63e-05	0.000305	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TPI1—osteoporosis	1.62e-05	0.000303	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—P4HB—osteoporosis	1.62e-05	0.000302	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—POMC—osteoporosis	1.62e-05	0.000302	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ESR1—osteoporosis	1.6e-05	0.000298	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GAPDH—osteoporosis	1.59e-05	0.000296	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—MTHFR—osteoporosis	1.58e-05	0.000295	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6R—osteoporosis	1.58e-05	0.000294	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IRS1—osteoporosis	1.57e-05	0.000292	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IGF1—osteoporosis	1.56e-05	0.00029	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—RAP1A—osteoporosis	1.55e-05	0.000289	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—P4HB—osteoporosis	1.52e-05	0.000284	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CA2—osteoporosis	1.5e-05	0.000281	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—OXCT1—osteoporosis	1.5e-05	0.000281	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ADCY5—osteoporosis	1.5e-05	0.000279	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GAPDH—osteoporosis	1.5e-05	0.000279	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GPX1—osteoporosis	1.49e-05	0.000278	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6R—osteoporosis	1.47e-05	0.000274	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MGLL—osteoporosis	1.47e-05	0.000274	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—RAP1A—osteoporosis	1.46e-05	0.000272	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MYC—osteoporosis	1.44e-05	0.000268	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—MTHFR—osteoporosis	1.38e-05	0.000257	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.32e-05	0.000247	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—POMC—osteoporosis	1.26e-05	0.000236	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ENO1—osteoporosis	1.25e-05	0.000233	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—IDH2—osteoporosis	1.25e-05	0.000233	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PSMA2—osteoporosis	1.23e-05	0.00023	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PSMA5—osteoporosis	1.23e-05	0.00023	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ENO1—osteoporosis	1.18e-05	0.00022	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.17e-05	0.000219	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PSMA2—osteoporosis	1.16e-05	0.000217	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PSMA5—osteoporosis	1.16e-05	0.000217	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ACP5—osteoporosis	1.14e-05	0.000213	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—POMC—osteoporosis	1.1e-05	0.000205	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—osteoporosis	1.1e-05	0.000204	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ADCY5—osteoporosis	1.08e-05	0.000202	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GPX1—osteoporosis	1.08e-05	0.000201	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TPI1—osteoporosis	1.06e-05	0.000198	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP19A1—osteoporosis	9.99e-06	0.000186	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—P4HB—osteoporosis	9.96e-06	0.000186	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MTHFR—osteoporosis	9.95e-06	0.000186	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GAPDH—osteoporosis	9.78e-06	0.000183	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—RAP1A—osteoporosis	9.53e-06	0.000178	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP19A1—osteoporosis	9.42e-06	0.000176	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—osteoporosis	9.35e-06	0.000174	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TGFB1—osteoporosis	9.32e-06	0.000174	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—osteoporosis	8.71e-06	0.000163	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TGFB1—osteoporosis	8.69e-06	0.000162	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—osteoporosis	8.31e-06	0.000155	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ADCY5—osteoporosis	8.16e-06	0.000152	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GPX1—osteoporosis	8.14e-06	0.000152	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—POMC—osteoporosis	7.96e-06	0.000149	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ENO1—osteoporosis	7.7e-06	0.000144	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ADCY5—osteoporosis	7.69e-06	0.000144	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GPX1—osteoporosis	7.67e-06	0.000143	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PSMA5—osteoporosis	7.59e-06	0.000142	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PSMA2—osteoporosis	7.59e-06	0.000142	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MTHFR—osteoporosis	7.51e-06	0.00014	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MTHFR—osteoporosis	7.08e-06	0.000132	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6—osteoporosis	7.03e-06	0.000131	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6—osteoporosis	6.55e-06	0.000122	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.16e-06	0.000115	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—POMC—osteoporosis	6e-06	0.000112	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—POMC—osteoporosis	5.66e-06	0.000106	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ADCY5—osteoporosis	5.03e-06	9.39e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GPX1—osteoporosis	5.01e-06	9.35e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MTHFR—osteoporosis	4.63e-06	8.63e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—POMC—osteoporosis	3.7e-06	6.9e-05	CbGpPWpGaD
